VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 201–300 of 1,013
Krzywinska, E., Kantari-Mimoun, C., Kerdiles, Y., Sobecki, M., Isagawa, T., Gotthardt, D., Castells, M., Haubold, J., Millien, C., Viel, T., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01599-w · Cited by 176
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization
Kawamura, H., Li, X., Goishi, K., van Meeteren, L. A., Jakobsson, L., Cébe-Suarez, S., Shimizu, A., Edholm, D., Ballmer-Hofer, K., Kjellén, L., et al. (2008) · Blood · doi:10.1182/blood-2007-12-125856 · Cited by 171
Biological Basis of Therapeutic Lymphangiogenesis
Norrmén, C., Tammela, T., Petrova, T. V., & Alitalo, K. (2011) · Circulation · doi:10.1161/circulationaha.107.704098 · Cited by 171
VEGF/VEGFR signalling as a target for inhibiting angiogenesis
Kiselyov, A., Balakin, K. V., & Tkachenko, S. E. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.83 · Cited by 172
Role of the endothelium in inflammatory bowel diseases
Cromer, W. E. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i5.578 · Cited by 172
Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review
Perlikos, F., Harrington, K. J., & Syrigos, K. N. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.12.007 · Cited by 174
Zhang, Y., Lu, Y., Ma, L., Cao, X., Xiao, J., Chen, J., Jiao, S., Gao, Y., Liu, C., Duan, Z., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.013 · Cited by 172
“One of the key functions of VEGF-C ligation is to increase VEGFR-3 phosphorylation and kinase activity (Olsson et al., 2006).”
InfluentialNourse, M. B., Halpin, D. E., Scatena, M., Mortisen, D. J., Tulloch, N. L., Hauch, K. D., Torok-Storb, B., Ratner, B. D., Pabon, L., & Murry, C. E. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194233 · Cited by 168
Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review
Curigliano, G., Mayer, E. L., Burstein, H. J., Winer, E. P., & Goldhirsch, A. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.05.006 · Cited by 166
Perfusable branching microvessel bed for vascularization of engineered tissues
Chiu, L. L. Y., Montgomery, M., Liang, Y., Liu, H., & Radisic, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210580109 · Cited by 171
“For example, activation of the ERK pathway regulates proliferation (27); activation of the p38 MAPK, PI3K, and Rac pathways regulates migration (28–30); and activation of Src regulates both migration and vascular permeability (29).”
BackgroundVEGF-A Stimulates ADAM17-Dependent Shedding of VEGFR2 and Crosstalk Between VEGFR2 and ERK Signaling
Swendeman, S., Mendelson, K., Weskamp, G., Horiuchi, K., Deutsch, U., Scherle, P., Hooper, A., Rafii, S., & Blobel, C. P. (2008) · Circulation Research · doi:10.1161/circresaha.108.184416 · Cited by 164
VEGFRs and Notch: a dynamic collaboration in vascular patterning
Jakobsson, L., Bentley, K., & Gerhardt, H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371233 · Cited by 162
Lu, J., Zhang, K., Nam, S., Anderson, R. A., Jove, R., & Wen, W. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp292 · Cited by 167
Chu, L.-Y., Ramakrishnan, D. P., & Silverstein, R. L. (2013) · Blood · doi:10.1182/blood-2013-01-482315 · Cited by 167
Reis, M., Czupalla, C. J., Ziegler, N., Devraj, K., Zinke, J., Seidel, S., Heck, R., Thom, S., Macas, J., Bockamp, E., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111580 · Cited by 167
“Furthermore, high VEGF expression in tumors is known to lead to SMC and PC drop off and to increase vessel permeability (Olsson et al., 2006).”
BackgroundBiomarkers in triple negative breast cancer: A review
Yadav, B. S., Chanana, P., & Jhamb, S. (2015) · World Journal of Clinical Oncology · doi:10.5306/wjco.v6.i6.252 · Cited by 192
Design principles for therapeutic angiogenic materials
Briquez, P. S., Clegg, L. E., Martino, M. M., Gabhann, F. M., & Hubbell, J. A. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2015.6 · Cited by 166
Jin, J., Sison, K., Li, C., Tian, R., Wnuk, M., Sung, H.-K., Jeansson, M., Zhang, C., Tucholska, M., Jones, N., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.037 · Cited by 161
“Similar to GM3, heparin also possesses a highly negative charge density (Figure S5C) and is known to bind to extracellular domains of VEGF receptors, including sFLT1 (Olsson et al., 2006; Park and Lee, 1999).”
Chen, J., Zhang, X., Liu, X., Zhang, C., Shang, W., Xue, J., Chen, R., Xing, Y., Song, D., & Xu, R. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172418 · Cited by 167
Matsuno, H., Tsuchimine, S., O’Hashi, K., Sakai, K., Hattori, K., Hidese, S., Nakajima, S., Chiba, S., Yoshimura, A., Fukuzato, N., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01618-3 · Cited by 164
“VEGFR2 inhibition suppressed BBB permeability and depressive-like behavior in chronic RS mice VEGF increases vascular permeability through VEGFR2 activation [25, 44, 45].”
BackgroundBarkefors, I., Le Jan, S., Jakobsson, L., Hejll, E., Carlson, G., Johansson, H., Jarvius, J., Park, J. W., Li Jeon, N., & Kreuger, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704917200 · Cited by 163
Self-citationVEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2–dependent Ca 2+ signaling
Favia, A., Desideri, M., Gambara, G., D’Alessio, A., Ruas, M., Esposito, B., Del Bufalo, D., Parrington, J., Ziparo, E., Palombi, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406029111 · Cited by 161
“Jha A, Ahuja M, Patel S, Brailoiu E, Muallem S (2014) Convergent regulation of the lysosomal two-pore channel-2 by Mg, NAADP, PI(3,5)P2 and multiple protein kinases.”
BackgroundInfluentialRanchoux, B., Harvey, L. D., Ayon, R. J., Babicheva, A., Bonnet, S., Chan, S. Y., Yuan, J. X. ‐., & Pérez, V. D. J. (2017) · Pulmonary Circulation · doi:10.1177/2045893217752912 · Cited by 172
“One of the most important is the vascular endothelial growth factor (VEGF) pathway, a crucial regulator of vascular development.(22,23) In the setting of hypoxia, there is an increase in the expression of the ligand VEGF-A, which upon its release interacts with the VEGF receptor (VEGFR) 2 and triggers a complex signal…”
BackgroundHuang, W., Yan, Z., Li, D., Ma, Y., Zhou, J., & Sui, Z. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1862462 · Cited by 156
“In endothelial cells, the PI3K-Akt pathway is robustly activated by VEGF, and Akt activates eNOS [35].”
BackgroundImplications of vascular endothelial growth factor for postischemic neurovascular remodeling
Hermann, D. M., & Zechariah, A. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.100 · Cited by 162
“In humans, the VEGF family consists of five homodimeric members (VEGF-A, VEGF-B, VEGF-C, VEGF-D and placental growth factor), among which VEGF-A stimulates angiogenesis in a particularly powerful manner (Olsson et al, 2006; Hansen et al, 2008).”
BackgroundA Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
Kong, D.-H., Kim, M., Jang, J., Na, H.-J., & Lee, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081786 · Cited by 161
“Interaction of T-cell-specific adaptor protein with VEGFR-2 leads to the activation of Akt signaling, which determines endothelial cell shape, adhesion, survival, and vessel permeability [32,39,40].”
BackgroundInfluentialManaging diabetic macular edema: The leading cause of diabetes blindness
Romero‐Aroca, P. (2011) · World Journal of Diabetes · doi:10.4239/wjd.v2.i6.98 · Cited by 164
Singh, R. P., Raina, K., Sharma, G., & Agarwal, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1309 · Cited by 161
Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition
Shi, S., Srivastava, S. P., Kanasaki, M., He, J., Kitada, M., Nagai, T., Nitta, K., Takagi, S., Kanasaki, K., & Koya, D. (2015) · Kidney International · doi:10.1038/ki.2015.103 · Cited by 166
KATOH, M. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1444 · Cited by 156
“VEGF activates the eNOS, SRC, RAS-ERK and PI3K-AKT signaling cascades through VEGFR2 receptor on endothelial cells, which induce vascular permeability, endothelial migration, proliferation and survival, respectively (6,7).”
BackgroundPoly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis
Tentori, L., Lacal, P. M., Muzi, A., Dorio, A. S., Leonetti, C., Scarsella, M., Ruffini, F., Xu, W., Min, W., Stoppacciaro, A., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.010 · Cited by 159
和田, 純., Suzuki, H. Y., Fuchino, R., Yamasaki, A., Nagai, S., Yanai, K., Koga, K., Nakamura, M., Tanaka, M., Morisaki, T., et al. (2009) · PubMed · Cited by 169
Liu, T., Ma, W., Xu, H., Huang, M., Zhang, D., He, Z., Zhang, L., Brem, S., O’Rourke, D. M., Gong, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05982-z · Cited by 151
Qiu, X., Liu, J., Zheng, C., Su, Y.-T., Bao, L., Zhu, B., Liu, S., Wang, L., Wang, X., Wang, Y., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12830 · Cited by 164
Modulation of VEGF signalling output by the Notch pathway
Siekmann, A. F., Covassin, L., & Lawson, N. D. (2008) · BioEssays · doi:10.1002/bies.20736 · Cited by 173
Nowacka, M. M., & Obuchowicz, E. (2012) · Neuropeptides · doi:10.1016/j.npep.2011.05.005 · Cited by 157
Endocan: A novel circulating proteoglycan
Kali, A., & Shetty, K. S. R. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.144891 · Cited by 159
“pathway, protein kinase B (AKT/PKB)/PI3K pathway, p38 MAPK pathway, PKC/nuclear factor-κB (NF-κB) pathway, and focal adhesion kinase pathway.[22] Among these, PKC/NF-κB”
Kawamura, H., Li, X., Harper, S. J., Bates, D. O., & Claesson-Welsh, L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6577 · Cited by 156
Heier, J. S., Boyer, D. S., Nguyen, Q. D., Marcus, D. M., Roth, D. B., Yancopoulos, G. D., Stahl, N., Ingerman, A., Vitti, R., Berliner, A. J., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.03.020 · Cited by 156
Structure of a VEGF–VEGF receptor complex determined by electron microscopy
Ruch, C., Skiniotis, G., Steinmetz, M. O., Walz, T., & Ballmer‐Hofer, K. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1202 · Cited by 155
VEGF regulates local inhibitory complement proteins in the eye and kidney
Keir, L. S., Firth, R., Aponik, L., Feitelberg, D., Sakimoto, S., Aguilar, E., Welsh, G. I., Richards, A., Usui, Y., Satchell, S. C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86418 · Cited by 154
“However, VEGF/VEGFR2 signaling is complex (34) and there are several other points at which modulation could occur: (a) interactions between receptor and coreceptors such as the neuropilins (34, 65) or extracellular matrix molecules such as integrins (66) or the cellular glycocalyx (67); (b) receptor internalization, r…”
BackgroundERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish
Ren, B., Deng, Y., Mukhopadhyay, A., Lanahan, A. A., Zhuang, Z. W., Moodie, K. L., Mulligan-Kehoe, M. J., Byzova, T. V., Peterson, R. T., & Simons, M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39837 · Cited by 151
Role and Regulation of Vascularization Processes in Endochondral Bones
Maes, C. (2013) · Calcified Tissue International · doi:10.1007/s00223-012-9689-z · Cited by 168
A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain
Selvaraj, D., Gangadharan, V., Michalski, C. W., Kurejová, M., Stösser, S., Srivastava, K., Schweizerhof, M., Waltenberger, J. L., Ferrara, N., Heppenstall, P. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.017 · Cited by 163
“Signaling Mediators of VEGFR1 and Their Contribution to Nociceptive Hypersensitivity VEGFRs activate diverse intracellular signaling targets (Figure 3A; Olsson et al., 2006).”
BackgroundInfluentialChen, M.-C., Hsu, W.-L., Hwang, P.-A., & Chou, T.-C. (2015) · Marine Drugs · doi:10.3390/md13074436 · Cited by 147
Gelfand, M. V., Hagan, N., Tata, A., Oh, W.-J., Lacoste, B., Kang, K.-T., Kopycinska, J., Bischoff, J., Wang, J.-H., & Gu, C. (2014) · eLife · doi:10.7554/elife.03720 · Cited by 148
“The main receptor for VEGF, VEGFR2, is a receptor tyrosine kinase whose activity is crucial for VEGF signaling ( Olsson et al., 2006 ).”
BackgroundAngiomotin regulates endothelial cell migration during embryonic angiogenesis
Aase, K., Ernkvist, M., Ebarasi, L., Jakobsson, L., Majumdar, A., Yi, C., Birot, O., Ming, Y., Kvanta, A., Edholm, D., et al. (2007) · Genes & Development · doi:10.1101/gad.432007 · Cited by 149
“…et al. 1996; Ferrara et al. 1996) and exerts its function by binding to two high-affinity receptor tyrosine kinases, VEGF receptor 1 (VEGFR1) and VEGFR2 (for review, see Olsson et al. 2006), and the coreceptors neuropilin 1 (NP-1) and NP-2 (Soker et al. 1998; Gluzman-Poltorak et al. 2000).”
BackgroundVEGF Mediates Commissural Axon Chemoattraction through Its Receptor Flk1
Ruiz de Almodovar, C., Fabre, P. J., Knevels, E., Coulon, C., Segura, I., Haddick, P. C. G., Aerts, L., Delattin, N., Strasser, G., Oh, W.-J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.014 · Cited by 139
“, 2009), whereas VEGF stimulates endothelial cell migration via SFK activation (Eliceiri et al., 2002; Olsson et al., 2006).”
Therapeutic Angiogenesis: Controlled Delivery of Angiogenic Factors
Chu, H., & Wang, Y. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.50 · Cited by 168
Mahoney, E. R., Dumitrescu, L., Moore, A. M., Cambronero, F. E., De Jager, P. L., Koran, M. E. I., Petyuk, V. A., Robinson, R. A. S., Goyal, S., Schneider, J. A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0458-5 · Cited by 150
NADPH Oxidase Activity Selectively Modulates Vascular Endothelial Growth Factor Signaling Pathways
Abid, M. R., Spokes, K. C., Shih, S.-C., & Aird, W. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702175200 · Cited by 150
Exercise Training and Peripheral Arterial Disease
Haas, T. L., Lloyd, P. G., Yang, H., & Terjung, R. L. (2012) · Comprehensive physiology · doi:10.1002/cphy.c110065 · Cited by 176
Marron, M. B., Singh, H., Tahir, T. A., Kavumkal, J., Kim, H.-Z., Koh, G. Y., & Brindle, N. P. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702535200 · Cited by 148
Boeckel, J., Guarani, V., Koyanagi, M., Roexe, T., Lengeling, A., SCHERMULY, R. T., Gellert, P., Braun, T. W., Zeiher, A. M., & Dimmeler, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008098108 · Cited by 159
Current concepts related to hypertrophic scarring in burn injuries
Chiang, R. S., Borovikova, A. A., King, K., Banyard, D. A., Lalezari, S., Toranto, J. D., Paydar, K. Z., Wirth, G. A., Evans, G. R. D., & Widgerow, A. D. (2016) · Wound Repair and Regeneration · doi:10.1111/wrr.12432 · Cited by 166
Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization
Brozzo, M. S., Bjelić, S., Kisko, K., Schleier, T., Leppänen, V., Alitalo, K. K., Winkler, F. K., & Ballmer‐Hofer, K. (2011) · Blood · doi:10.1182/blood-2011-11-390922 · Cited by 154
Cooperative and redundant roles of VEGFR‐2 and VEGFR‐3 signaling in adult lymphangiogenesis
Goldman, J., Rutkowski, J. M., Shields, J. D., Pasquier, M. C., Cui, Y., Schmoekel, H. G., Willey, S., Hicklin, D. J., Pytowski, B., & Swartz, M. A. (2007) · The FASEB Journal · doi:10.1096/fj.06-6656com · Cited by 148
Protein post-translational modifications in the regulation of cancer hallmarks
Wang, H., Yang, L., Liu, M., & Luo, J. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00464-3 · Cited by 160
Weskamp, G., Mendelson, K., Swendeman, S., Le Gall, S., Ma, Y., Lyman, S., Hinoki, A., Eguchi, S., Guaiquil, V., Horiuchi, K., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.207415 · Cited by 146
Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity.
Rufaihah, A. J., Huang, N. F., Kim, J., Herold, J., Volz, K. S., Park, T. S., Lee, J. C., Zambidis, E. T., Pera, R. A. R., & Cooke, J. P. (2013) · Europe PMC (PubMed Central) · Cited by 146
Mural Cell Associated VEGF Is Required for Organotypic Vessel Formation
Evensen, L., Micklem, D. R., Blois, A., Berge, S. V., Aarsæther, N., Littlewood-Evans, A., Wood, J., & Lorens, J. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005798 · Cited by 145
“Together with our observation that soluble VEGF cannot substitute for mural cell-expressed VEGF this supports the notion that these VEGF presentation forms are functionally distinct [35].”
BackgroundClinical Pharmacology of Axitinib
Chen, Y., Tortorici, M. A., Garrett, M., Hee, B., Klamerus, K. J., & Pithavala, Y. K. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0068-3 · Cited by 146
“The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling pathways are critical not only for normal vascular development during embryogenesis and angiogenesis later in adults, but also have been implicated in the survival, growth and metastasis of tumors [1–3].”
BackgroundVEGFR-2 conformational switch in response to ligand binding
Sarabipour, S., Ballmer‐Hofer, K., & Hristova, K. A. (2016) · eLife · doi:10.7554/elife.13876 · Cited by 147
“We compared the structural effects of several ligands known to bind to VEGFR-2, namely three different VEGF-A isoforms (VEGF-A121, VEGF-A165a, and VEGF-A165b), as well as VEGF-C, VEGF-D, and VEGF-E.”
BackgroundInfluentialCurrent insights into the metastasis of epithelial ovarian cancer - hopes and hurdles
Yousefi, M., Dehghani, S., Nosrati, R., Ghanei, M., Salmaninejad, A., Rajaie, S., Hasanzadeh, M., & Pasdar, A. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00513-9 · Cited by 152
Nodine, M. D., Yadegari, R., & Tax, F. E. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.003 · Cited by 146
Transcriptional Regulation of Endothelial Cell and Vascular Development
Park, C., Kim, T., & Malik, A. B. (2013) · Circulation Research · doi:10.1161/circresaha.113.301078 · Cited by 156
Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration
Finger, R. P., Wickremasinghe, S. S., Baird, P. N., & Guymer, R. H. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2013.03.009 · Cited by 144
Behr, B., Tang, C., Germann, G., Longaker, M. T., & Quarto, N. (2011) · Stem Cells · doi:10.1002/stem.581 · Cited by 137
Bible, E., Qutachi, O., Chau, D. Y. S., Alexander, M. R., Shakesheff, K. M., & Modo, M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.085 · Cited by 144
“One of the most potent angiogenic molecules is vascular endothelial growth factor (VEGF) [10].”
Falcón, B. L., Chintharlapalli, S. R., Uhlik, M. T., & Pytowski, B. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.001 · Cited by 149
Tumor Origin of Endothelial Cells in Human Neuroblastoma
Pezzolo, A., Parodi, F., Corrias, M. V., Cinti, R., Gambini, C., & Pistoia, V. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0696 · Cited by 139
Lin, Y.-D., Luo, C.-Y., Hu, Y.-N., Yeh, M.-L., Hsueh, Y.-C., Chang, M.-Y., Tsai, D.-C., Wang, J.-N., Tang, M.-J., Wei, E. I. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003841 · Cited by 142
Wang, G., Sun, M., Jiang, Y., Zhang, T., Sun, W. Y., Wang, H., Yin, F., Wang, Z., Sang, W., Xu, J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32180 · Cited by 154
“The binding of VEGF to VEGFR2 results in the phosphorylation of VEGFR2 and the activation of the downstream signaling molecules STAT3, Akt and Erk-1/2, which promote endothelial cell growth, migration and survival.(46) Indirectly targeting VEGF and its receptors may be one of the most effective strategies for treating…”
BackgroundPerlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis
Zoeller, J. J., Whitelock, J. M., & Iozzo, R. V. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.04.010 · Cited by 150
“…investigated the influence of a perlecan-VEGF interaction on endothelial cell function vis-à-vis activation of VEGFR2, the major signaling receptor tyrosine kinase which mediates multiple events during the angiogenic cascade in response to VEGF-A ligands (Olsson et al., 2006; Dai and Rabie, 2007).”
BackgroundVascularisation of the central nervous system
Tata, M., Ruhrberg, C., & Fantin, A. (2015) · Mechanisms of Development · doi:10.1016/j.mod.2015.07.001 · Cited by 136
“2) (Olsson et al., 2006).”
BackgroundDimerization of VEGF receptors and implications for signal transduction: A computational study
Gabhann, F. M., & Popel, A. S. (2007) · Biophysical Chemistry · doi:10.1016/j.bpc.2007.03.010 · Cited by 142
“Vascular endothelial growth factor (VEGF) is a critical regulator of angiogenesis [4,5], a cytokine which carries activating, proliferative and chemotactic signals from hypovascularized tissues to endothelial cells of quiescent blood vessels and initiates new vessel sprouting to increase perfusion of the target tissue.”
BackgroundFraser, S. P., Ozerlat‐Gunduz, I., Brackenbury, W. J., Fitzgerald, E. M., Campbell, T. M., Coombes, R. C., & Djamgoz, M. B. A. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0105 · Cited by 152
“(d) Vascular endothelial growth factor Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis [97] which also involves invasive cell behaviour [98].”
BackgroundAhmad, S., Hewett, P. W., Wang, P., Al-Ani, B., Cudmore, M., Fujisawa, T., Haigh, J. J., le Noble, F., Wang, L., Mukhopadhyay, D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000243989.46006.b9 · Cited by 140
Schmidt, T., Masouleh, B. K., Loges, S., Cauwenberghs, S., Fraisl, P., Maes, C., Jonckx, B., Keersmaecker, K. D., Kleppe, M., Tjwa, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.007 · Cited by 148
Ligand‐Stimulated VEGFR2 Signaling is Regulated by Co‐Ordinated Trafficking and Proteolysis
Bruns, A. F., Herbert, S. P., Odell, A. F., Jopling, H. M., Hooper, N. M., Zachary, I. C., Walker, J. H., & Ponnambalam, S. (2010) · Traffic · doi:10.1111/j.1600-0854.2009.01001.x · Cited by 135
“A key hallmark of VEGF-A stimulation of VEGFR2 is activation of c-Akt, a downstream serine/threonine protein kinase which then phosphorylates and activates eNOS, leading to increased nitric oxide production and vasodilation (35).”
BackgroundExtracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma
Treps, L., Edmond, S., Harford‐Wright, E., Galán‐Moya, E. M., Schmitt, A., Azzi, S., Citerne, A., Bidère, N., Ricard, D., & Gavard, J. (2015) · Oncogene · doi:10.1038/onc.2015.317 · Cited by 143
Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels
Rauniyar, K., Jha, S. K., & Jeltsch, M. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00007 · Cited by 154
“With certain exceptions (Olsson et al., 2006), they are only expressed by endothelial cells.”
BackgroundSignaling pathways in the development of infantile hemangioma
Ji, Y., Chen, S., Li, K., Li, L., Xu, C., & Xiang, B. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-13 · Cited by 145
“Phosphorylation in turn elicits differential downstre angiogenic effects of VEGF-A, including microvascular permeability, EC proliferation, migration and survival [34].”
BackgroundSingle-cell and spatial atlases of spinal cord injury in the Tabulae Paralytica
Skinnider, M. A., Gautier, M., Teo, A. Y. Y., Kathe, C., Hutson, T. H., Laskaratos, A., de Coucy, A., Regazzi, N., Aureli, V., James, N. D., et al. (2024) · Nature · doi:10.1038/s41586-024-07504-y · Cited by 160
“Moreover, it is established that the delivery of VEGF accelerates endothelial cell proliferation and reformation of vascular networks 57 .”
Targeted inhibition of VEGF receptor 2: an update on ramucirumab
Clarke, J. M., & Hurwitz, H. I. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.810717 · Cited by 142
“VEGFC and VEGFD signaling through VEGFR2, which may play a possible role in resistance to VEGFA-targeted therapies, would be blocked with ramucirumab.”
BackgroundInfluentialVascular Endothelial Cell-specific MicroRNA-15a Inhibits Angiogenesis in Hindlimb Ischemia
Yin, K., Olsen, K. F., Hamblin, M., Zhang, J., Schwendeman, S. P., & Chen, Y. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364414 · Cited by 136
“More specifically, vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), transforming growth factor- (TGF- ), and epidermal growth factor (EGF) can induce the division of cultured endothelial cells, thus indicating a direct action on these cells (7, 8).”
BackgroundCourau, T., Nehar-Belaid, D., Florez, L., Levacher, B., Vazquez, T., Brimaud, F., Bellier, B., & Klatzmann, D. (2016) · JCI Insight · doi:10.1172/jci.insight.85974 · Cited by 131
“VEGF is a major regulator of tumor angiogenesis (22), but also a powerful inhibitor of DC maturation Tregs imprint an early immunotolerant tumor environment that prevents effective antitumor immune responses.”
BackgroundWeijts, B. G. M. W., Bakker, W. J., Cornelissen, P. W. A., Liang, K.-H., Schaftenaar, F. H., Westendorp, B., de Wolf, C. A. C. M. T., Paciejewska, M., Scheele, C. L. G. J., Kent, L. N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.231 · Cited by 138
“VEGFA acts as a chemoattractant that binds as a homodimer to receptor tyrosine kinase 1 and 2 (respectively FLT1 and FLK1/KDR) found on endothelial cells (Olsson et al , 2006).”
Pratheeshkumar, P., Son, Y., Budhraja, A., Wang, X., Ding, S., Wang, L., Hitron, J. A., Lee, J., Kim, D., Divya, S. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052279 · Cited by 140
“VEGFR2 is essential for the morphogenesis of vascular endothelium and is the primary receptor mediating the angiogenic activity of VEGF through distinct signal transduction pathways that regulate endothelial cell proliferation, migration, differentiation and tube formation [62–64].”
BackgroundSemaphorin-3B Is an Angiogenesis Inhibitor That Is Inactivated by Furin-Like Pro-Protein Convertases
Varshavsky, A., Kessler, O., Abramovitch, S., Kigel, B., Zaffryar, S., Akiri, G., & Neufeld, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5408 · Cited by 130
Li, W., Man, X., Li, C., Chen, J., Zhou, J., Cai, S., Lu, Z., & Zheng, M. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.05.003 · Cited by 135
Fu, X., Yang, Y., Li, X., Lai, H., Huang, Y., He, L., Zheng, W., & Chen, T. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.01.012 · Cited by 140
Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib
Welti, J. C., Gourlaouen, M., Powles, T. B., Kudahetti, S. C., Wilson, P. A., Berney, D. M., & Reynolds, A. R. (2010) · Oncogene · doi:10.1038/onc.2010.503 · Cited by 141
“VEGF-A drives angiogenesis by signalling through two cognate receptors on local endothelial cells, VEGFR1 and VEGFR2 (Ferrara et al., 2003; Olsson et al., 2006).”
InfluentialCystathionine β‐synthase regulates endothelial function via protein S ‐sulfhydration
Saha, S., Chakraborty, P. K., Xiong, X., Dwivedi, S. K. D., Mustafi, S. B., Leigh, N. R., Ramchandran, R., Mukherjee, P., & Bhattacharya, R. (2015) · The FASEB Journal · doi:10.1096/fj.15-278648 · Cited by 134
“To determine how CBS regulates EC function, we focused on the VEGF/VEGFR-2 signaling axis, arguably the predominant pathway responsible for EC proliferation, migration, and survival (28).”
BackgroundWang, H., Ran, H.-F., Yin, Y., Xu, X., Jiang, B.-X., Yu, S.-Q., Chen, Y., Ren, H., Feng, S., Zhang, J., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00803-4 · Cited by 136
“There are much evidences that VEGFR2 delivers key mitogenic, angiogenic and permeability-enhancing signals of VEGF, and is the major mediator of endothelial cells mitogenesis and survival, as well as angiogenesis and microvascular permeability [23, 24].”
BackgroundVascular endothelial growth factor (VEGF) regulates cranial neural crest migration in vivo
McLennan, R., Teddy, J. M., Kasemeier‐Kulesa, J. C., Romine, M. H., & Kulesa, P. M. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.12.022 · Cited by 140
The role of chemokines and their receptors in angiogenesis
Kiefer, F., & Siekmann, A. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0677-7 · Cited by 140
“Members of the vascular endothelial growth factor (VEGF) family have been shown to control many aspects of endothelial biology, including proliferation, differentiation, migration and survival [2].”
BackgroundHeparin desulfation modulates VEGF release and angiogenesis in diabetic wounds.
Freudenberg, U., Zieris, A., Chwalek, K., Tsurkan, M., Maitz, M., Atallah, P., Levental, K., Eming, S., & Werner, C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.028 · Cited by 118
Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye
Sene, A., Chin-Yee, D., & Apte, R. S. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.10.005 · Cited by 130
VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
D’Haene, N., Sauvage, S., Maris, C., Adanja, I., Mercier, M. L., Decaestecker, C., Baum, L., & Salmon, I. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067029 · Cited by 129
“Galectin-1 and galectin-3 have been shown to activate ERK1/2 and FAK, respectively [3,5], and the major pathways of VEGFR2 signal transduction include ERK1/2, Akt, Src, FAK and Hsp27 activation [27].”
Background
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.